Engels CV, Zapardiel GI, Valero BJ, San Frutos LL, Bajo AJM

Language: Spanish
References: 11
Page: 355-361
PDF size: 339.21 Kb.

ABSTRACT

Aims: The utility of the valuation-measurement of the nasal bone in the prognosis of chromosomopaties during the second trimester of the pregnancy is demonstrated.
Objective: To evaluate the repeatability of nasal bone measurement during second trimester with bidimensional and three-dimensional sonography.
Material and method: Nasal bone was measured in 50 single pregnancies. First observer carried out two measures of nasal bone with bidimensional sonography, and 1 measure with three-dimensional sonography. Second observer carried out just one measure with bidimensional sonography (2D) and just another one with three-dimensional sonography (3D). We studied the intraobserver variability with 2D sonography, and the interobserver variability with 2D and 3D sonography.
Results: 2D-sonography: nasal bone measurement showed excellent intraobserver correlation with a correlation coefficient of 0,87 (CI 95%: 0,78-0,93) and a little means difference of 0,18 (SD: 0,74). Indeed, there was a good interobserver correlation with a correlation coefficient of 0,92 (CI 95%: 0,85-0,95), and a means difference of 0,14 (SD: 0,56). 3D-sonography: there was a acceptable interobserver correlation with correlation coefficient of 0,70 (CI 95%: 0,52-0,82).
Conclusion: Nasal bone measurement is highly reproducible by means of bidimensional sonography while using three-dimensional sonography, the results are just acceptable.

REFERENCES

1. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191(1):45-67.

2. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001;358:1665-7.

3. Kanellopoulos V, Katsetos C, Economides DL. Examination of fetal nasal bone and repeatability of measurement in early pregnancy. Ultrasound Obstet Gynecol 2003;22:131-4.

4. Cicero S, Sonek JD, Mckenna DS, Croom CS, et al. Nasal bone hypoplasia in trisomy 21 at 15-22 weeks gestation. Ultrasound Obstet Gynecol 2003;21(1):15-18.

5. Cicero S, Dezerega V, Andrade E, Scheier M, Nicolaides KH. Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks. Ultrasound Obstet Gynecol 2003;22(2):135-7.

6. Senat MV, Bernard JP, Boulvain M, Ville Y. Intra- and interoperator variability in fetal nasal bone assessment at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2003;22(2):138-41.

7. Benoit B, Chaoui R. Three-dimensional ultrasound with maximal mode rendering: a novel technique for the diagnosis of bilateral or unilateral absence or hypoplasia of nasal bones in econd-trimester screening for Down syndrome. Ultrasound Obstet Gynecol 2005;25(1):19-24.

8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.

9. Gamez F, Ferreiro P, Salmean JM. Ultrasonographic measurement of fetal nasal bone in a low-risk population at 19-22 gestational weeks. Ultrasound Obstet Gynecol 2004;23(2):152-3.

10. Vintzileos A, Walters C, Yeo L. Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk population. Obstet Gynecol 2003;101(5, Part 1):905-8.

11. Bekker MN, Twisk JW, Van Vugt J. Reproducibility of the fetal nasal bone length measurement. J Ultrasound Med 2004;23:1613-8.